Clinical Medicine
Listando 64 trabajos del autor/autora 38
Lista de trabajos en el área Clinical Medicine
Mentions
129
Twitter
0
Wikipedia
80
News
0
Policy
Article
Hepatocellular carcinoma
Llovet, Josep M.; Kelley, Robin Kate; Villanueva, Augusto; Singal, Amit G.; Pikarsky, Eli; Roayaie, Sasan; Lencioni, Riccardo; Koike, Kazuhiko; Zucman-Rossi, Jessica; Finn, Richard S.
NATURE REVIEWS DISEASE PRIMERS
2056-676X (2021)
DOI /
10.1038/s41572-020-00240-3
Bronze
Mentions
16
Twitter
0
Wikipedia
47
News
0
Policy
Article
Immunomodulatory Effects of Lenvatinib Plus Anti-Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma
Torrens, Laura; Montironi, Carla; Puigvehi, Marc; Mesropian, Agavni; Leslie, Jack; Haber, Philipp K.; Maeda, Miho; Balaseviciute, Ugne; Willoughby, Catherine E.; Abril-Fornaguera, Jordi; Pique-Gili, Marta; Torres-Martin, Miguel; Peix, Judit; Geh, Daniel; R
HEPATOLOGY
0270-9139 (2021)
DOI /
10.1002/hep.32023
Mentions
63
Twitter
2
Wikipedia
52
News
4
Policy
Article
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Bruix, Jordi; Qin, Shukui; Merle, Philippe; Granito, Alessandro; Huang, Yi-Hsiang; Bodoky, Gyrogy; Pracht, Marc; Yokosuka, Osamu; Rosmorduc, Olivier; Breder, Valeriy; Gerolami, Rene; Masi, Gianluca; Ross, Paul J.; Song, Tianqiang; Bronowicki, Jean-Pierre;
LANCET
0140-6736 (2017)
DOI /
10.1016/s0140-6736(16)32453-9
Green published
Mentions
85
Twitter
1
Wikipedia
7
News
1
Policy
Article
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased alpha-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Zhu, Andrew X.; Kang, Yoon-Koo; Yen, Chia-Jui; Finn, Richard S.; Galle, Peter R.; Llovet, Josep M.; Assenat, Eric; Brandi, Giovanni; Pracht, Marc; Lim, Ho Yeong; Rau, Kun-Ming; Motomura, Kenta; Ohno, Izumi; Merle, Philippe; Daniele, Bruno; Shin, Dong Bok;
LANCET ONCOLOGY
1470-2045 (2019)
DOI /
10.1016/s1470-2045(18)30937-9
Mentions
180
Twitter
0
Wikipedia
1
News
0
Policy
Review
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
Llovet, Josep M.; de Baere, Thierry; Kulik, Laura; Haber, Philipp K.; Greten, Tim F.; Meyer, Tim; Lencioni, Riccardo
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY
1759-5045 (2021)
DOI /
10.1038/s41575-020-00395-0
Mentions
4
Twitter
0
Wikipedia
12
News
0
Policy
Article
Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-Mutated Hepatocellular Carcinoma
Lim, Ho Yeong; Merle, Philippe; Weiss, Karl Heinz; Yau, Thomas; Ross, Paul; Mazzaferro, Vincenzo; Blanc, Jean-Frederic; Ma, Yuk Ting; Yen, Chia Jui; Kocsis, Judit; Choo, Su Pin; Sukeepaisarnjaroen, Wattana; Gerolami, Rene; Dufour, Jean-Francois; Gane, Edwa
CLINICAL CANCER RESEARCH
1078-0432 (2018)
DOI /
10.1158/1078-0432.ccr-17-3588
Bronze, Green published
Mentions
133
Twitter
0
Wikipedia
2
News
0
Policy
Review
Immunotherapies for hepatocellular carcinoma
Llovet, Josep M.; Castet, Florian; Heikenwalder, Mathias; Maini, Mala K.; Mazzaferro, Vincenzo; Pinato, David J.; Pikarsky, Eli; Zhu, Andrew X.; Finn, Richard S.
NATURE REVIEWS CLINICAL ONCOLOGY
1759-4774 (2021)
DOI /
10.1038/s41571-021-00573-2
Mentions
189
Twitter
0
Wikipedia
0
News
0
Policy
Article
beta-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma
de Galarreta, Marina Ruiz; Bresnahan, Erin; Molina-Sanchez, Pedro; Lindblad, Katherine E.; Maier, Barbara; Sia, Daniela; Puigvehi, Marc; Miguela, Vernica; Casanova-Acebes, Maria; Dhainaut, Maxime; Villacorta-Martin, Carlos; Singhi, Aatur D.; Moghe, Akshata
CANCER DISCOVERY
2159-8274 (2019)
DOI /
10.1158/2159-8290.cd-19-0074
Hybrid, Green accepted
Mentions
88
Twitter
0
Wikipedia
1
News
0
Policy
Article
Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
Pinyol, Roser; Torrecilla, Sara; Wang, Huan; Montironi, Carla; Pique-Gili, Marta; Torres-Martin, Miguel; Wei-Qiang, Leow; Willoughby, Catherine E.; Ramadori, Pierluigi; Andreu-Oller, Carmen; Taik, Patricia; Lee, Youngmin A.; Moeini, Agrin; Peix, Judit; Fau
JOURNAL OF HEPATOLOGY
0168-8278 (2021)
DOI /
10.1016/j.jhep.2021.04.049
Mentions
55
Twitter
0
Wikipedia
2
News
0
Policy
Article
Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types
Pare, L.; Pascual, T.; Segui, E.; Teixido, C.; Gonzalez-Cao, M.; Galvan, P.; Rodriguez, A.; Gonzalez, B.; Cuatrecasas, M.; Pineda, E.; Torne, A.; Crespo, G.; Martin-Algarra, S.; Perez-Ruiz, E.; Reig, O.; Viladot, M.; Font, C.; Adamo, B.; Vidal, M.; Gaba, L
ANNALS OF ONCOLOGY
0923-7534 (2018)
DOI /
10.1093/annonc/mdy335
Bronze
Mentions
95
Twitter
0
Wikipedia
0
News
0
Policy
Article
Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations
Affo, Silvia; Nair, Ajay; Brundu, Francesco; Ravichandra, Aashreya; Bhattacharjee, Sonakshi; Matsuda, Michitaka; Chin, LiKang; Filliol, Aveline; Wen, Wen; Song, Xinhua; Decker, Aubrianna; Worley, Jeremy; Caviglia, Jorge Matias; Yu, Lexing; Yin, Deqi; Saito
CANCER CELL
1535-6108 (2021)
DOI /
10.1016/j.ccell.2021.03.012
Mentions
25
Twitter
0
Wikipedia
4
News
0
Policy
Article
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Vogel, A.; Cervantes, A.; Chau, I.; Daniele, B.; Llovet, J.; Meyer, T.; Nault, J. -C.; Neumann, U.; Ricke, J.; Sangro, B.; Schirmacher, P.; Verslype, C.; Zech, C. J.; Arnold, D.; Martinelli, E.
ANNALS OF ONCOLOGY
0923-7534 (2018)
DOI /
10.1093/annonc/mdy308
Green published, Gold other
Mentions
27
Twitter
0
Wikipedia
2
News
0
Policy
Article
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
Sia, Daniela; Jiao, Yang; Martinez-Quetglas, Iris; Kuchuk, Olga; Villacorta-Martin, Carlos; de Moura, Manuel Castro; Putra, Juan; Camprecios, Genis; Bassaganyas, Laia; Akers, Nicholas; Losic, Bojan; Waxman, Samuel; Thung, Swan N.; Mazzaferro, Vincenzo; Est
GASTROENTEROLOGY
0016-5085 (2017)
DOI /
10.1053/j.gastro.2017.06.007
Green accepted
Mentions
55
Twitter
0
Wikipedia
2
News
0
Policy
Article
Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
Finn, Richard S.; Ikeda, Masafumi; Zhu, Andrew X.; Sung, Max W.; Baron, Ari D.; Kudo, Masatoshi; Okusaka, Takuji; Kobayashi, Masahiro; Kumada, Hiromitsu; Kaneko, Shuichi; Pracht, Marc; Mamontov, Konstantin; Meyer, Tim; Kubota, Tomoki; Dutcus, Corina E.; Sa
JOURNAL OF CLINICAL ONCOLOGY
0732-183X (2020)
DOI /
10.1200/jco.20.00808
Green published, Gold other
Mentions
91
Twitter
0
Wikipedia
0
News
0
Policy
Article
Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity
Moeini, Agrin; Sia, Daniela; Zhang, Zhongyang; Camprecios, Genis; Stueck, Ashley; Dong, Hui; Montal, Robert; Torrens, Laura; Martinez-Quetglas, Iris; Fiel, M. Isabel; Hao, Ke; Villanueva, Augusto; Thung, Swan N.; Schwartz, Myron E.; Llovet, Josep M.
JOURNAL OF HEPATOLOGY
0168-8278 (2017)
DOI /
10.1016/j.jhep.2017.01.010
Green accepted
Mentions
21
Twitter
0
Wikipedia
2
News
0
Policy
Article
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications
Carrillo-Reixach, Juan; Torrens, Laura; Simon-Coma, Marina; Royo, Laura; Domingo-Sabat, Montserrat; Abril-Fornaguera, Jordi; Akers, Nicholas; Sala, Margarita; Ragull, Sonia; Arnal, Magdalena; Villalmanzo, Nuria; Cairo, Stefano; Villanueva, Alberto; Kappler
JOURNAL OF HEPATOLOGY
0168-8278 (2020)
DOI /
10.1016/j.jhep.2020.03.025
Green published, Hybrid
Mentions
56
Twitter
0
Wikipedia
0
News
0
Policy
Article
DNA Methylation Profiling of Human Hepatocarcinogenesis
Hernandez-Meza, Gabriela; von Felden, Johann; Gonzalez-Kozlova, Edgar E.; Garcia-Lezana, Teresa; Peix, Judit; Portela, Anna; Craig, Amanda J.; Sayols, Sergi; Schwartz, Myron; Losic, Bojan; Mazzaferro, Vincenzo; Esteller, Manel; Llovet, Josep M.; Villanueva
HEPATOLOGY
0270-9139 (2021)
DOI /
10.1002/hep.31659
Bronze
Mentions
61
Twitter
0
Wikipedia
0
News
0
Policy
Review
Molecular therapies and precision medicine for hepatocellular carcinoma
Llovet, Josep M.; Montal, Robert; Sia, Daniela; Finn, Richard S.
NATURE REVIEWS CLINICAL ONCOLOGY
1759-4774 (2018)
DOI /
10.1038/s41571-018-0073-4
Green accepted
Mentions
63
Twitter
0
Wikipedia
0
News
0
Policy
Review
Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival
Llovet, Josep M.; Montal, Robert; Villanueva, Augusto
JOURNAL OF HEPATOLOGY
0168-8278 (2019)
DOI /
10.1016/j.jhep.2019.01.028
Bronze, Green accepted
Mentions
28
Twitter
0
Wikipedia
1
News
0
Policy
Article
Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma
Nault, Jean-Charles; Martin, Yoann; Caruso, Stefano; Hirsch, Theo Z.; Bayard, Quentin; Calderaro, Julien; Charpy, Cecile; Copie-Bergman, Christiane; Ziol, Marianne; Bioulac-Sage, Paulette; Couchy, Gabrielle; Blanc, Jean-Frederic; Nahon, Pierre; Amaddeo, Gi
HEPATOLOGY
0270-9139 (2019)
DOI /
10.1002/hep.30811
Mentions
61
Twitter
0
Wikipedia
0
News
0
Policy
Article
International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma
Singal, Amit G.; Hoshida, Yujin; Pinato, David J.; Marrero, Jorge; Nault, Jean-Charles; Paradis, Valerie; Tayob, Nabihah; Sherman, Morris; Lim, Young Suk; Feng, Ziding; Lok, Anna S.; Rinaudo, Jo Ann; Srivastava, Sudhir; Llovet, Josep M.; Villanueva, August
GASTROENTEROLOGY
0016-5085 (2021)
DOI /
10.1053/j.gastro.2021.01.233
Bronze
Mentions
49
Twitter
0
Wikipedia
0
News
0
Policy
Article
Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer
von Felden, Johann; Garcia-Lezana, Teresa; Dogra, Navneet; Gonzalez-Kozlova, Edgar; Ahsen, Mehmet Eren; Craig, Amanda; Gifford, Stacey; Wunsch, Benjamin; Smith, Joshua T.; Kim, Sungcheol; Diaz, Jennifer E. L.; Chen, Xintong; Labgaa, Ismail; Haber, Philipp;
GUT
0017-5749 (2021)
DOI /
10.1136/gutjnl-2021-325036
Mentions
30
Twitter
0
Wikipedia
1
News
0
Policy
Review
Biology and significance of alpha-fetoprotein in hepatocellular carcinoma
Galle, Peter R.; Foerster, Friedrich; Kudo, Masatoshi; Chan, Stephen L.; Llovet, Josep M.; Qin, Shukui; Schelman, William R.; Chintharlapalli, Sudhakar; Abada, Paolo B.; Sherman, Morris; Zhu, Andrew X.
LIVER INTERNATIONAL
1478-3223 (2019)
DOI /
10.1111/liv.14223
Hybrid
Mentions
22
Twitter
0
Wikipedia
0
News
0
Policy
Article
Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma
Bollard, Julien; Miguela, Veronica; de Galarreta, Marina Ruiz; Venkatesh, Anu; Bian, C. Billie; Roberto, Mark P.; Tovar, Victoria; Sia, Daniela; Molina-Sanchez, Pedro; Nguyen, Christie B.; Nakagawa, Shigeki; Llovet, Josep M.; Hoshida, Yujin; Lujambio, Amai
GUT
0017-5749 (2017)
DOI /
10.1136/gutjnl-2016-312268
Green published, Green accepted, Hybrid
Mentions
31
Twitter
0
Wikipedia
0
News
0
Policy
Article
Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma
von Felden, Johann; Craig, Amanda J.; Garcia-Lezana, Teresa; Labgaa, Ismail; Haber, Philipp K.; D'Avola, Delia; Asgharpour, Amon; Dieterich, Douglas; Bonaccorso, Antoinette; Torres-Martin, Miguel; Sia, Daniela; Sung, Max W.; Tabrizian, Parissa; Schwartz, M
ONCOGENE
0950-9232 (2020)
DOI /
10.1038/s41388-020-01519-1
Mentions
0
Twitter
1
Wikipedia
2
News
0
Policy
Editorial Material
Milestones in the pathogenesis and management of primary liver cancer
Nault, Jean-Charles; Cheng, Ann-Lii; Sangro, Bruno; Llovet, Josep M.
JOURNAL OF HEPATOLOGY
0168-8278 (2020)
DOI /
10.1016/j.jhep.2019.11.006
Bronze
Mentions
31
Twitter
0
Wikipedia
0
News
1
Policy
Article
Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
Bruix, Jordi; Cheng, Ann-Lii; Meinhardt, Gerold; Nakajima, Keiko; De Sanctis, Yoriko; Llovet, Josep
JOURNAL OF HEPATOLOGY
0168-8278 (2017)
DOI /
10.1016/j.jhep.2017.06.026
Gold other
Mentions
17
Twitter
0
Wikipedia
1
News
0
Policy
Article
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial
Pinyol, Roser; Montal, Robert; Bassaganyas, Laia; Sia, Daniela; Takayama, Tadatoshi; Chau, Gar-Yang; Mazzaferro, Vincenzo; Roayaie, Sasan; Lee, Han Chu; Kokudo, Norihiro; Zhang, Zhongyang; Torrecilla, Sara; Moeini, Agrin; Rodriguez-Carunchio, Leonardo; Gan
GUT
0017-5749 (2019)
DOI /
10.1136/gutjnl-2018-316408
Green published, Hybrid
Mentions
28
Twitter
0
Wikipedia
0
News
0
Policy
Article
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma
Montal, Robert; Sia, Daniela; Montironi, Carla; Leow, Wei Q.; Esteban-Fabro, Roger; Pinyol, Roser; Torres-Martin, Miguel; Bassaganyas, Laia; Moeini, Agrin; Peix, Judit; Cabellos, Laia; Maeda, Miho; Villacorta-Martin, Carlos; Tabrizian, Parissa; Rodriguez-C
JOURNAL OF HEPATOLOGY
0168-8278 (2020)
DOI /
10.1016/j.jhep.2020.03.008
Green accepted
Mentions
21
Twitter
0
Wikipedia
0
News
0
Policy
Article
Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials
Montal, Robert; Andreu-Oller, Carmen; Bassaganyas, Laia; Esteban-Fabro, Roger; Moran, Sebastian; Montironi, Carla; Moeini, Agrin; Pinyo, Roser; Peix, Judit; Cabellos, Laia; Villanueva, Augusto; Sia, Daniela; Mazzaferro, Vincenzo; Esteller, Manel; Llovet, J
BRITISH JOURNAL OF CANCER
0007-0920 (2019)
DOI /
10.1038/s41416-019-0513-7
Green published, Hybrid
Mentions
4
Twitter
0
Wikipedia
1
News
0
Policy
Article
Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades
Puigvehi, Marc; Hashim, Dana; Haber, Philipp K.; Dinani, Amreen; Schiano, Thomas D.; Asgharpour, Amon; Kushner, Tatyana; Kakked, Gaurav; Tabrizian, Parissa; Schwartz, Myron; Gurakar, Ahmet; Dieterich, Douglas; Boffetta, Paolo; Friedman, Scott L.; Llovet, J
AMERICAN JOURNAL OF TRANSPLANTATION
1600-6135 (2019)
DOI /
10.1111/ajt.15576
Bronze, Green accepted
Mentions
8
Twitter
0
Wikipedia
1
News
0
Policy
Article
Liver Injury Increases the Incidence of HCC following AAV Gene Therapy in Mice
Dalwadi, Dhwanil A.; Torrens, Laura; Abril-Fornaguera, Jordi; Pinyol, Roser; Willoughby, Catherine; Posey, Jeffrey; Llovet, Josep M.; Lanciault, Christian; Russell, David W.; Grompe, Markus; Naugler, Willscott E.
MOLECULAR THERAPY
1525-0016 (2021)
DOI /
10.1016/j.ymthe.2020.10.018
Mentions
21
Twitter
0
Wikipedia
0
News
0
Policy
Review
Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002-2020)
Haber, Philipp K.; Puigvehi, Marc; Castet, Florian; Lourdusamy, Vennis; Montal, Robert; Tabrizian, Parissa; Buckstein, Michael; Kim, Edward; Villanueva, Augusto; Schwartz, Myron; Llovet, Josep M.
GASTROENTEROLOGY
0016-5085 (2021)
DOI /
10.1053/j.gastro.2021.06.008
Mentions
29
Twitter
0
Wikipedia
0
News
0
Policy
Review
The oncogenic role of hepatitis delta virus in hepatocellular carcinoma
Puigvehi, Marc; Moctezuma-Velazquez, Carlos; Villanueva, Augusto; Llovet, Josep M.
JHEP REPORTS
(2019)
DOI /
10.1016/j.jhepr.2019.05.001
Mentions
21
Twitter
0
Wikipedia
0
News
0
Policy
Article
A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma
Labgaa, Ismail; Villacorta-Martin, Carlos; D'Avola, Delia; Craig, Amanda J.; von Felden, Johann; Martins-Filho, Sebastiao N.; Sia, Daniela; Stueck, Ashley; Ward, Stephen C.; Fiel, M. Isabel; Mahajan, Milind; Tabrizian, Parissa; Thung, Swan N.; Ang, Celina;
ONCOGENE
0950-9232 (2018)
DOI /
10.1038/s41388-018-0206-3
Green accepted
Mentions
3
Twitter
0
Wikipedia
1
News
0
Policy
Article
Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma
Teufel, Michael; Seidel, Henrik; Koechert, Karl; Meinhardt, Gerold; Finn, Richard S.; Llovet, Josep M.; Bruix, Jordi
GASTROENTEROLOGY
0016-5085 (2019)
DOI /
10.1053/j.gastro.2019.01.261
Gold other, Green accepted
Mentions
25
Twitter
0
Wikipedia
0
News
0
Policy
Article
Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma
Torrecilla, Sara; Sia, Daniela; Harrington, Andrew N.; Zhang, Zhongyang; Cabellos, Laia; Cornella, Helena; Moeini, Agrin; Camprecios, Genis; Leow, Wei-Qiang; Fiel, Maria Isabel; Hao, Ke; Bassaganyas, Laia; Mahajan, Milind; Thung, Swan N.; Villanueva, Augus
JOURNAL OF HEPATOLOGY
0168-8278 (2017)
DOI /
10.1016/j.jhep.2017.08.013
Green accepted
Mentions
13
Twitter
0
Wikipedia
0
News
0
Policy
Review
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference
Llovet, Josep M.; Villanueva, Augusto; Marrero, Jorge A.; Schwartz, Myron; Meyer, Tim; Galle, Peter R.; Lencioni, Riccardo; Greten, Tim F.; Kudo, Masatoshi; Mandrekar, Sumithra J.; Zhu, Andrew X.; Finn, Richard S.; Roberts, Lewis R.
HEPATOLOGY
0270-9139 (2020)
DOI /
10.1002/hep.31327
Mentions
16
Twitter
0
Wikipedia
0
News
0
Policy
Editorial Material
Immune Exclusion-Wnt/CTNNB1 Class Predicts Resistance to Immunotherapies in HCC
Pinyol, Roser; Sia, Daniela; Llovet, Josep M.
CLINICAL CANCER RESEARCH
1078-0432 (2019)
DOI /
10.1158/1078-0432.ccr-18-3778
Green accepted, Bronze
Mentions
11
Twitter
0
Wikipedia
0
News
0
Policy
Article
Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma
Gallon, John; Coto-Llerena, Mairene; Ercan, Caner; Bianco, Gaia; Paradiso, Viola; Nuciforo, Sandro; Taha-Melitz, Stephanie; Meier, Marie-Anne; Boldanova, Tujana; Perez-del-Pulgar, Sofia; Rodriguez-Tajes, Sergio; von Flue, Markus; Soysal, Savas D.; Kollmar,
MOLECULAR ONCOLOGY
(2021)
DOI /
10.1002/1878-0261.13154
Mentions
14
Twitter
0
Wikipedia
0
News
0
Policy
Article
Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC
Lencioni, Riccardo; Montal, Robert; Torre, Ferran; Park, Joong-Won; Decaens, Thomas; Raoul, Jean-Luc; Kudo, Masatoshi; Chang, Charissa; Rios, Jose; Boige, Valerie; Assenat, Eric; Kang, Yoon-Koo; Lim, Ho-Yeong; Walters, Ian; Llovet, Josep M.
JOURNAL OF HEPATOLOGY
0168-8278 (2017)
DOI /
10.1016/j.jhep.2017.01.012
Green accepted
Mentions
13
Twitter
0
Wikipedia
0
News
0
Policy
Editorial Material
Cohort Profile: Design and methods of the PREDIMED-Plus randomized trial
Martinez-Gonzalez, Miguel A.; Buil-Cosiales, Pilar; Corella, Dolores; Bullo, Monica; Fito, Montserrat; Vioque, Jesus; Romaguera, Dora; Alfredo Martinez, J.; Warnberg, Julia; Lopez-Miranda, Jose; Estruch, Ramon; Bueno-Cavanillas, Aurora; Aros, Fernando; Tur
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
0300-5771 (2019)
DOI /
10.1093/ije/dyy225
Green published, Bronze
Mentions
6
Twitter
0
Wikipedia
0
News
0
Policy
Article
Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma
Tovar, Victoria; Cornella, Helena; Moeini, Agrin; Vidal, Samuel; Hoshida, Yujin; Sia, Daniela; Peix, Judit; Cabellos, Laia; Alsinet, Clara; Torrecilla, Sara; Martinez-Quetglas, Iris; Jose Lozano, Juan; Desbois-Mouthon, Christele; Sole, Manel; Domingo-Domen
GUT
0017-5749 (2017)
DOI /
10.1136/gutjnl-2015-309501
Green accepted
Mentions
6
Twitter
0
Wikipedia
0
News
0
Policy
Article
Pilot study of living donor liver transplantation for patients with hepatocellular carcinoma exceeding Milan Criteria (Barcelona Clinic Liver Cancer extended criteria)
Llovet, Josep M.; Pavel, Mihai; Rimola, Jordi; Alba Diaz, Maria; Colmenero, Jordi; Saavedra-Perez, David; Fondevila, Constantino; Ayuso, Carmen; Fuster, Josep; Gines, Pere; Bruix, Jordi; Carlos Garcia-Valdecasas, Juan
LIVER TRANSPLANTATION
1527-6465 (2018)
DOI /
10.1002/lt.24977
Green accepted
Mentions
10
Twitter
0
Wikipedia
0
News
0
Policy
Editorial Material
Atezolizumab plus Bevacizumab: A Novel Breakthrough in Hepatocellular Carcinoma
Castet, Florian; Willoughby, Catherine E.; Haber, Philipp K.; Llovet, Josep M.
CLINICAL CANCER RESEARCH
1078-0432 (2021)
DOI /
10.1158/1078-0432.ccr-20-4706
Mentions
9
Twitter
0
Wikipedia
0
News
0
Policy
Article
An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents
Moeini, Agrin; Torrecilla, Sara; Tovar, Victoria; Montironi, Carla; Andreu-Oller, Carmen; Peix, Judit; Higuera, Monica; Pfister, Dominik; Ramadori, Pierluigi; Pinyol, Roser; Sole, Manel; Heikenwaelder, Mathias; Friedman, Scott L.; Sia, Daniela; Llovet, Jos
GASTROENTEROLOGY
0016-5085 (2019)
DOI /
10.1053/j.gastro.2019.07.028
Green published, Bronze, Green accepted
Mentions
5
Twitter
0
Wikipedia
0
News
0
Policy
Article
Non-invasive imaging criteria for the diagnosis of hepatocellular carcinoma in non-cirrhotic patients with chronic hepatitis B
Moctezuma-Velazquez, Carlos; Lewis, Sara; Lee, Karen; Amodeo, Salvatore; Llovet, Josep M.; Schwartz, Myron; Abraldes, Juan G.; Villanueva, Augusto
JHEP REPORTS
(2021)
DOI /
10.1016/j.jhepr.2021.100364
Mentions
6
Twitter
0
Wikipedia
0
News
0
Policy
Article
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
Sia, Daniela; Villanueva, Augusto; Friedman, Scott L.; Llovet, Josep M.
GASTROENTEROLOGY
0016-5085 (2017)
DOI /
10.1053/j.gastro.2016.11.048
Bronze, Green accepted
Mentions
7
Twitter
0
Wikipedia
0
News
0
Policy
Article
Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology
Galle, Peter R.; Kudo, Masatoshi; Llovet, Josep M.; Finn, Richard S.; Karwal, Mark; Pezet, Denis; Kim, Tae-You; Yang, Tsai-Sheng; Lonardi, Sara; Tomasek, Jiri; Phelip, Jean-Marc; Touchefeu, Yann; Koh, Su-Jin; Stirnimann, Guido; Liang, Kun; Ogburn, Kenyon D
LIVER INTERNATIONAL
1478-3223 (2021)
DOI /
10.1111/liv.14994
Green accepted, Hybrid
Mentions
9
Twitter
0
Wikipedia
0
News
0
Policy
Article
Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2
Kudo, Masatoshi; Galle, Peter R.; Llovet, Josep M.; Finn, Richard S.; Vogel, Arndt; Motomura, Kenta; Assenat, Eric; Merle, Philippe; Brandi, Giovanni; Daniele, Bruno; Okusaka, Takuji; Tomasek, Jiri; Borg, Christophe; Dadduzio, Vincenzo; Morimoto, Manabu; P
LIVER INTERNATIONAL
1478-3223 (2020)
DOI /
10.1111/liv.14462
Gold other
Mentions
13
Twitter
0
Wikipedia
0
News
0
Policy
Article
Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2
Kudo, Masatoshi; Galle, Peter R.; Brandi, Giovanni; Kang, Yoon-Koo; Yen, Chia-Jui; Finn, Richard S.; Llovet, Josep M.; Assenat, Eric; Merle, Philippe; Chan, Stephen L.; Palmer, Daniel H.; Ikeda, Masafumi; Yamashita, Tatsuya; Vogel, Arndt; Huang, Yi-Hsiang;
JHEP REPORTS
(2021)
DOI /
10.1016/j.jhepr.2020.100215
Mentions
4
Twitter
0
Wikipedia
0
News
0
Policy
Article
Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2)
Kudo, Masatoshi; Finn, Richard S.; Morimoto, Manabu; Rau, Kun-Ming; Ikeda, Masafumi; Yen, Chia-Jui; Galle, Peter R.; Llovet, Josep M.; Daniele, Bruno; Lim, Ho Yeong; McIlwain, David W.; Yoshikawa, Reigetsu; Nakamura, Kenichi; Liang, Kun; Wang, Chunxiao; Ab
LIVER CANCER
2235-1795 (2021)
DOI /
10.1159/000516605
Gold
Mentions
3
Twitter
0
Wikipedia
0
News
0
Policy
Article
R-spondin 2 Drives Liver Tumor Development in a Yes-Associated Protein-Dependent Manner
Conboy, Caitlin B.; Velez-Reyes, German L.; Tschida, Barbara R.; Hu, Hsiangyu; Kaufmann, Gabriel; Koes, Nicholas; Keller, Bryant; Alsinet, Clara; Cornella, Helena; Pinyol, Roser; Abrahante, Juan E.; Temiz, Nuri A.; Linden, Michael A.; Amin, Khalid; Kuka, T
HEPATOLOGY COMMUNICATIONS
(2019)
DOI /
10.1002/hep4.1422
Gold DOAJ, Green published
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Article
Liver Cancer Disparities in New York City: A Neighborhood View of Risk and Harm Reduction Factors
Kamath, Geetanjali R.; Taioli, Emanuela; Egorova, Natalia N.; Llovet, Josep M.; Perumalswami, Ponni V.; Weiss, Jeffrey J.; Schwartz, Myron; Ewala, Stanley; Bickell, Nina A.
FRONTIERS IN ONCOLOGY
2234-943X (2018)
DOI /
10.3389/fonc.2018.00220
Gold DOAJ, Green published
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
DNA Methylation Signatures Reveal the Diversity of Processes Remodeling Hepatocellular Carcinoma Methylomes
Meunier, Lea; Hirsch, Theo Z.; Caruso, Stefano; Imbeaud, Sandrine; Bayard, Quentin; Roehrig, Amelie; Couchy, Gabrielle; Nault, Jean-Charles; Llovet, Josep M.; Blanc, Jean-Frederic; Calderaro, Julien; Zucman-Rossi, Jessica; Letouze, Eric
HEPATOLOGY
0270-9139 (2021)
DOI /
10.1002/hep.31796
Green published
Mentions
4
Twitter
0
Wikipedia
0
News
0
Policy
Article
Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular Carcinoma
Bassaganyas, Laia; Pinyol, Roser; Esteban-Fabro, Roger; Torrens, Laura; Torrecilla, Sara; Willoughby, Catherine E.; Franch-Exposito, Sebastia; Vila-Casadesus, Maria; Salaverria, Itziar; Montal, Robert; Mazzaferro, Vincenzo; Camps, Jordi; Sia, Daniela; Llov
CLINICAL CANCER RESEARCH
1078-0432 (2020)
DOI /
10.1158/1078-0432.ccr-20-1497
Green accepted
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab
Reig, Maria; Galle, Peter R.; Kudo, Masatoshi; Finn, Richard; Llovet, Josep M.; Metti, Andrea L.; Schelman, William R.; Liang, Kun; Wang, Chunxiao; Widau, Ryan C.; Abada, Paolo; Zhu, Andrew X.
LIVER INTERNATIONAL
1478-3223 (2020)
DOI /
10.1111/liv.14731
Gold other, Green published
Mentions
4
Twitter
0
Wikipedia
0
News
0
Policy
Letter
Reply to: "mRECIST for systemic therapies: More evidence is required before recommendations could be made"
Montal, Robert; Lencioni, Riccardo; Llovet, Josep M.
JOURNAL OF HEPATOLOGY
0168-8278 (2017)
DOI /
10.1016/j.jhep.2017.03.004
Mentions
4
Twitter
0
Wikipedia
0
News
0
Policy
Review
Cabozantinib: An evolving therapy for hepatocellular carcinoma
El-Khoueiry, Anthony B.; Hanna, Diana L.; Llovet, Josep; Kelley, Robin Kate
CANCER TREATMENT REVIEWS
0305-7372 (2021)
DOI /
10.1016/j.ctrv.2021.102221
Gold other
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Letter
Negative phase 3 study of Y-90 microspheres versus sorafenib in HCC
Llovet, Josep M.; Finn, Richard S.
LANCET ONCOLOGY
1470-2045 (2018)
DOI /
10.1016/s1470-2045(18)30025-1
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Article
Imaging-based surrogate markers of transcriptome subclasses and signatures in hepatocellular carcinoma: preliminary results
Taouli, Bachir; Hoshida, Yujin; Kakite, Suguru; Chen, Xintong; Tan, Poh Seng; Sun, Xiaochen; Kihira, Shingo; Kojima, Kensuke; Toffanin, Sara; Fiel, M. Isabel; Hirschfield, Hadassa; Wagner, Mathilde; Llovet, Josep M.
EUROPEAN RADIOLOGY
0938-7994 (2017)
DOI /
10.1007/s00330-017-4844-6
Green accepted
Mentions
3
Twitter
0
Wikipedia
0
News
0
Policy
Letter
Reply to: "Predictors of sorafenib benefit in patients with hepatocellular carcinoma"
Bruix, Jordi; Cheng, Ann Lii; Llovet, Josep
JOURNAL OF HEPATOLOGY
0168-8278 (2018)
DOI /
10.1016/j.jhep.2017.10.013
Bronze
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Article
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab
Zhu, Andrew X.; Finn, Richard S.; Kang, Yoon-Koo; Yen, Chia-Jui; Galle, Peter R.; Llovet, Josep M.; Assenat, Eric; Brandi, Giovanni; Motomura, Kenta; Ohno, Izumi; Daniele, Bruno; Vogel, Arndt; Yamashita, Tatsuya; Hsu, Chih-Hung; Gerken, Guido; Bilbruck, Jo
BRITISH JOURNAL OF CANCER
0007-0920 (2021)
DOI /
10.1038/s41416-021-01260-w
Gold other
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Article
Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials
Zhu, Andrew X.; Nipp, Ryan D.; Finn, Richard S.; Galle, Peter R.; Llovet, Josep M.; Blanc, Jean-Frederic; Okusaka, Takuji; Chau, Ian; Cella, David; Girvan, Allicia; Gable, Jonathon; Bowman, Lee; Wang, Chunxiao; Hsu, Yanzhi; Abada, Paolo B.; Kudo, Masatoshi
ESMO OPEN
(2020)
DOI /
10.1136/esmoopen-2020-000797
Gold DOAJ, Green published
